HealingMaps is a technology company.
HealingMaps has raised $1.0M across 1 funding round.
HealingMaps has raised $1.0M in total across 1 funding round.
HealingMaps has raised $1.0M in total across 1 funding round.
HealingMaps's investors include Ambria Capital, Jenny Friedman, XEIA Venture Partners, Vinay Hiremath.
HealingMaps is a technology platform operating as a leading online directory and educational resource for psychedelic-assisted therapies, primarily focusing on ketamine clinics, psilocybin retreats, TMS (transcranial magnetic stimulation) providers, and integrative mental health treatments across the US and globally.[1][2][4] It serves patients seeking legal, evidence-based alternatives for mental health issues like depression and anxiety by providing clinic listings, honest information, and tools to compare providers—such as distinguishing standard ketamine infusions from more effective but costlier Ketamine-Assisted Psychotherapy (KAP), offered by only about 20% of clinics.[2][4] The company solves the problem of stigma, misinformation, and access barriers in the emerging psychedelic therapy sector, while demonstrating growth through a $1M seed round in 2022, a beta chatbot launch boosting engagement by 15% in 2024, and the 2025 formation of the Healing Health Alliance (HHA), a first-of-its-kind Group Purchasing Organization (GPO) joint venture to cut operational costs for clinics via bulk purchasing.[1]
HealingMaps emerged to combat decades of cultural stigma around psychedelics like ketamine, psilocybin, and LSD, providing accurate information at a pivotal moment when ketamine received FDA Breakthrough Therapy status in 2018, signaling a major industry shift.[2] Founded prior to its 2022 seed funding—led by Phyto Partners and Ambria Capital, with Cody Shandraw joining as Board Chairman—the platform was inspired by groundbreaking research expanding legal treatment access.[1][2] Cory Jones serves as CEO, steering early milestones like the 2022 funding close and subsequent innovations amid evolving regulations.[1] Key traction includes the 2024 chatbot beta with vellum.ai and the 2025 launch of HHA in partnership with Capstone Management Group and Advanced Behavioral Strategies, addressing rising clinic costs.[1]
HealingMaps rides the explosive growth of psychedelic-assisted therapies, fueled by FDA recognitions, regulatory evolution (e.g., potential psilocybin expansion), and mental health crises demanding alternatives to traditional treatments.[2] Timing is ideal amid post-2018 ketamine breakthroughs and rising clinic numbers, where market forces like high costs and stigma hinder scaling—HealingMaps counters this by bridging patients to providers and launching HHA to bolster clinic viability.[1][2] It influences the ecosystem by educating consumers, fostering clinic visibility (e.g., listings for centers like Freedom Ketamine), and introducing specialized tools like the Ketamine Insights newsletter and liability coverage guidance, accelerating adoption in a projected multi-billion-dollar industry.[1][4]
HealingMaps is poised to dominate as the psychedelic therapy "Google," expanding HHA into a full-service network amid regulatory tailwinds like state-level psilocybin legalization and federal research momentum.[1][2] Trends like AI-driven personalization (building on its chatbot) and GPO efficiencies will fuel clinic partnerships and revenue growth, potentially attracting Series A funding. Its influence could evolve from directory to ecosystem enabler—think integrated telehealth or global expansion—cementing its role in destigmatizing and scaling mental health innovation, much like early platforms transformed other health verticals.[1][2][4]
HealingMaps has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $1.0M Seed | Ambria Capital, Jenny Friedman, XEIA Venture Partners, Vinay Hiremath |